Neurology

Neurology

Home News Diseases Conferences Special Reports

HEADACHE

Headache is a very common problem presenting to primary care physicians and neurologists.
Most headaches are diagnosed based on the history & physical exam w/ no imaging or laboratory examination necessary.
Other types of headaches such as secondary headaches may require further evaluation & referral to a specialist.

Headache Patient Education

Patient Education

Education about the nature of the headache and reassurance that this is a common headache disorder which is not related to serious underlying disease should be given to the the patients
Reassurance is important and often effective on its own and should never be omitted
Explain the risk of medication overuse headache to patients who are undergoing acute treatment

Product Highlight - Pontevia

16 Mar 2022

Galcanezumab Injection

Long COVID: What we have learned so far

Prof. Ghassan Dbaibo, 27 Apr 2023

The WHO defines long COVID as a condition that occurs 3 months from COVID-19 onset, whose symptoms last ≥2 months and cannot be attributed to an alternative diagnosis. In an interview with MIMS Doctor, Professor Ghassan Dbaibo of the Center for Infectious Diseases, American University of Beirut, Beirut, Lebanon, describes the evolving attitudes towards long COVID among healthcare professionals (HCPs), some unexpected predisposing factors, potential biological mechanisms behind prolonged symptom duration and shares data on vaccination’s protective effects against long COVID.

$Fremanezumab: Sustained benefits across the board for refractory migraine$

Fremanezumab: Sustained benefits across the board for refractory migraine

Pearl Toh, 20200703182000

$LIBERTY: Erenumab shows sustained efficacy in refractory episodic migraine over 2 years$

LIBERTY: Erenumab shows sustained efficacy in refractory episodic migraine over 2 years

Pearl Toh, 20200701190000